Adaptive Biotechnologies Corp
XETRA:1HM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Adaptive Biotechnologies Corp
XETRA:1HM
|
US |
|
U
|
Unilever PLC
XHAN:UNV0
|
UK |
|
Prosafe SE
OSE:PRS
|
NO |
|
S
|
Seagate Technology Holdings PLC
XHAN:847
|
SG |
|
P
|
Parade Technologies Ltd
TPEX:4966
|
KY |
|
L
|
Linde PLC
XHAN:LIN
|
UK |
|
A
|
Adidas AG
XHAN:ADS
|
DE |
|
Unidata SpA
MIL:UD
|
IT |
|
Ependion AB
STO:EPEN
|
SE |
|
C
|
Chunghwa Precision Test Tech Co Ltd
TPEX:6510
|
TW |
|
Western Mining Co Ltd
SSE:601168
|
CN |
|
Wasion Holdings Ltd
OTC:WSIOF
|
HK |
|
Calbee Inc
OTC:CLBEY
|
JP |
|
NanoViricides Inc
F:NV3P
|
US |
|
M
|
Meta Platforms Inc
XHAN:FB2A
|
US |
|
F
|
Farmacosmo SpA
MIL:COSMO
|
IT |
|
F
|
freenet AG
XHAN:FNTN
|
DE |
|
E
|
EZCORP Inc
XBER:EZ2A
|
US |
|
Q
|
Q & M Dental Group (Singapore) Ltd
XBER:QMBN
|
SG |
|
I
|
Indus Holding AG
F:INH
|
DE |
|
B
|
Brembo SpA
LSE:0RPV
|
IT |
|
ACQ Bure AB
F:0FE
|
SE |
|
B
|
Brembo SpA
MIL:BRE
|
IT |
|
M
|
Mawson Gold Ltd
F:MXR
|
CA |
Wall St Price Targets
1HM Price Targets Summary
Adaptive Biotechnologies Corp
According to Wall Street analysts, the average 1-year price target for 1HM is 44.799 EUR with a low forecast of 38.95 EUR and a high forecast of 49.491 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1HM's stock price target?
Price Target
44.799
EUR
According to Wall Street analysts, the average 1-year price target for 1HM is 44.799 EUR with a low forecast of 38.95 EUR and a high forecast of 49.491 EUR.
What is the Revenue forecast for Adaptive Biotechnologies Corp?
Projected CAGR
19%
Over the last 7 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 5 years is 19%.
What is the Gross Profit forecast for Adaptive Biotechnologies Corp?
Projected CAGR
19%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 28%. The projected CAGR for the next 5 years is 19%.
